We are international
Donate
• health professionals TEXT SIZE   
   back

Dr. Jakubowiak - Targeted Therapy Against Clonogenic Myeloma Cells with Iodine I-131 Tositumomab (Bexxar™).
Andrzej Jakubowiak, MD
University of Michigan Cancer Center
Ann Arbor, MI
01.08.08

Be the first to comment

 related articles